Prestige Consumer Healthcare Inc (NYSE:PBH)
| 62.29 Delayed Data As of Mar 24 |  +0.01 / +0.02%Today’s Change | 48.51 Today|||52-Week Range 67.45 | -0.50% Year-to-Date |
Latest PBH News | Press Releases
No recent news for Prestige Consumer Healthcare Inc.
Today’s Trading
| Previous close | 62.28 |
| Today’s open | 61.02 |
| Day’s range | 60.70 - 62.46 |
| Volume | 194,562 |
| Average volume (3 months) | 274,696 |
| Market cap | $3.0B |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +24.59% |
| Earnings growth (this year) | +3.11% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | +15.21% |
| P/E ratio | 15.0 |
| Price/Sales | 2.48 |
| Price/Book | 1.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FOLDAmicus Therapeutics ... | -0.09 | -0.80% |
| RETAReata Pharmaceutical... | -2.26 | -2.57% |
| CYTKCytokinetics Inc | -0.27 | -0.80% |
| ACADACADIA Pharmaceutica... | -0.08 | -0.44% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | $1.04 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $205.4M |
| Net profit margin | 18.90% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
